KBC Group’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $63K | Sell |
4,495
-1,955
| -30% | -$27.4K | ﹤0.01% | 1476 |
|
|
2025
Q1 | $88K | Buy |
6,450
+116
| +2% | +$1.58K | ﹤0.01% | 1551 |
|
|
2024
Q4 | $129K | Buy |
6,334
+2,731
| +76% | +$55.6K | ﹤0.01% | 1382 |
|
|
2024
Q3 | $105K | Hold |
3,603
| – | – | ﹤0.01% | 1251 |
|
|
2024
Q2 | $84K | Buy |
3,603
+1,138
| +46% | +$26.5K | ﹤0.01% | 1272 |
|
|
2024
Q1 | $51K | Hold |
2,465
| – | – | ﹤0.01% | 1546 |
|
|
2023
Q4 | $53K | Hold |
2,465
| – | – | ﹤0.01% | 1482 |
|
|
2023
Q3 | $51K | Buy |
+2,465
| New | +$51K | ﹤0.01% | 1428 |
|